Catalog Advanced Search
-
Contains 1 Component(s)
Hosted by the Portal Hypertension SIG
Moderators: Patrick Northup, MD, FAASLD
Speakers: Constantine Karvellas, MD, SM, FRCPC, FCCM, Brian Buchanan
-
Contains 5 Component(s)
Plenary Lectures from the Annual Meeting
3067: President's Choice State of the Art Lecture: Digitized Medicine
3069: Thomas E. Starzl Liver Transplant State of the Art Lecture: Alcohol-Associated Liver Disease: Transplant Triumphs and Challenges
3102: Hyman J. Zimmerman State of the Art: New Diagnostic Approaches in Acetaminophen Acute Liver Injury
3060: Leon Schiff State of the Art: Personalized Approach to HCC
-
Contains 2 Product(s)
View on-demand presentations from The Liver Meeting® 2023. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics.
This package will include:
- The Postgraduate Course: Cirrhosis As a Multisystem Disorder
- 2023 TLM Debrief Sessions
- State of the Art Programs
-
Contains 7 Component(s)
11-14-2023
Speakers:
Rebecca Wells, MD: Basic Science Debrief
Juan Albraldes, MD: Portal Hypertension Debrief
Jennifer Price, MD, PhD: Hepatitis Debrief
Gideon Hirschfield, FRCP PhD: Cholestasis Debrief
Mazen Noureddin, MD, MHSc: MASLD Debrief
-
Contains 2 Product(s)
View on-demand presentations from The Liver Meeting® 2023.
View on-demand presentations from The Liver Meeting® 2023. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics.
-
Contains 1 Component(s)
Hosted by: Inclusion and Diversity Committee Moderator: Chimaobi Anugwom, MBBS Speaker: Julius Wilder, MD, PhD; Lorna Dove, MD, MPH
Evaluation of Webinar on 2/07
-
Contains 1 Component(s)
2024 Webinar
Hosted by: Inclusion and Diversity Committee
Moderator: Chimaobi Anugwom, MBBS
Speaker: Julius Wilder, MD, PhD; Lorna Dove, MD, MPH -
Contains 1 Component(s)
Hosted live on November 1, 2023 by the MASLD SIG.
The nomenclature change from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD) marks a significant advancement in liver disease understanding as it recognizes the role of metabolic factors beyond fat accumulation in liver disease. The webinar will delve into the rationale and purpose of this shift in nomenclature in its ability to foster interdisciplinary collaboration, enhance public health initiatives, and drive focused research in the various phenotypes within steatotic liver diseases for improved patient outcomes. Embracing MASLD heralds a future of effective liver disease management including pharmacologic and non-pharmacologic intervention(s) and empowers healthcare professionals to better understand and manage the disease.
Our audience will gain a better understanding of the rationale behind the nomenclature change in steatotic liver disease classification, specifically on the evolving evidence and concepts in liver disease pathophysiology that necessitated the shift in nomenclature. Emphasis will be placed on the clinical application of the new classification, exploring how it enables more accurate diagnoses and tailored interventions for patients. Lastly, its potential implications for future research and pharmacologic development, showcasing its role in advancing the field and improving patient outcomes.
-
Contains 28 Component(s)
This course will help prepare physicians for the American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP) certification and maintenance of certification (MOC) exam in transplant hepatology and pediatric transplant hepatology as it reflects the updated ABIM/ABP Transplant Hepatology Certification Exam blueprint. Designed for ABIM/ABP Transplant Hepatology exam preparation, high yield clinical topics will be presented by leaders in the field of hepatology and transplant medicine.
The 2022 AASLD Transplant Hepatology Board Review Course was released on Friday, August 15, 2020 as an on-demand course.
This course will help prepare physicians for the American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP) certification and maintenance of certification (MOC) exam in transplant hepatology and pediatric transplant hepatology as it reflects the updated ABIM/ABP Transplant Hepatology Certification Exam blueprint. High yield clinical topics will be presented by leaders in the field of hepatology and transplant medicine. Designed for ABIM/ABP Transplant Hepatology exam preparation, the course also provides a comprehensive review of up-to-date management of liver transplant patients.
COMPONENTS: Online presentations comprised of PowerPoint slides and accompanying audio, online pre- and post-tests and evaluations: - 25 online, narrated presentations 20 - 45 minutes in length - MOC quiz questions for each session - Evaluation for CME credit/ABIM and ABP MOC point offerings
DIRECTIONS: Review all section tabs before you begin. Start watching the presentation videos. Complete necessary components to claim either CME and ABIM and or ABP MOC.
HANDOUTS: To access, download and print the PDFs of each presentation, please head to the Handouts tab. Note, you will need to download the PDF to your device to proceed with printing.
CONTINUING EDUCATION: Continuing Medical Education (CME): 9.25 AMA PRA Category 1 Credits™ ABIM Maintenance of Certification (MOC): 9.25 ABIM MOC Points ABP Maintenance of Certification (MOC): 9.00 ABP MOC Points
HOW TO EARN AND CLAIM MOC POINTS: To claim both CME Credits and ABIM and or ABP MOC points for this activity you must:
- Watch each video presentation
- Complete each session post-test and pass with a score of 70% or higher (Participants have unlimited attempts to earn the passing score)
- Complete the Final Evaluation
- Claim CME credits (ABIM Rule: MOC points must be equivalent to the amount of CME credits claimed for the activity)
MOC completions are collected on the 15th of each month and submitted to the ABIM by the last day of the month. Points are not submitted automatically and will not display immediately on your ABIM MOC Profile. MOC points are available for ABIM and or ABP board certified physicians only.
Release Date: October 15, 2022 Expiration Date: October 15, 2024
COPYRIGHT: All faculty in this activity have given their permission for publication ©2022 AASLD.
-
Contains 4 Component(s), Includes Credits
Live activity to be held in Las Vegas in March 2024
This is a live activity to be held in Las Vegas, Nevada on March 8 - 9 2024. Topics will include:
- Multi-omic Approaches to Unraveling MASLD
- Precision medicine in MASLD- From big data to the individual
- Precision biomarkers for MASH and fibrosis
- Precision medicine in MASLD diagnostics
- Precision MASLD care today and looking ahead to 2034This activity will be offering CME/MOC credits:
Continuing Medical Education Credit (CME)
Accreditation Statement: The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AASLD designates this enduring activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation components, enables the participant to earn up to 12.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.